Impaired Glucose Tolerance is Associated with Enhanced Platelet-Monocyte Aggregation in Short-Term High-Fat Diet-Fed

Zibusiso Mkandla1, Tinashe Mutize1, Phiwayinkosi V Dludla2,3

  • 1School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.

Nutrients
|November 10, 2019
PubMed

Insights

High-fat diet (HFD) feeding promotes hypercoagulation by increasing platelet-monocyte aggregates (PMA). This early metabolic dysregulation links inflammation to cardiovascular risks.

Area of Science:

  • Metabolic research
  • Hematology
  • Cardiovascular science

Background:

  • High-fat diet (HFD) is known to cause metabolic dysregulation.
  • The impact of HFD on inducing a hypercoagulable state is not well understood.
  • Understanding the link between inflammation and hypercoagulation in early metabolic dysfunction is crucial.

Purpose of the Study:

  • To investigate the effect of short-term HFD feeding on platelet-monocyte aggregate (PMA) formation.
  • To assess the relationship between HFD-induced metabolic changes and hypercoagulation.
  • To determine if HFD promotes a hypercoagulable state.

Main Methods:

  • Mice were fed a HFD for 8 weeks.
  • Body weights, insulin, and blood glucose levels were monitored weekly.
  • Basal hematological measurements and spontaneous peripheral blood PMA levels were assessed using whole blood flow cytometry.

Main Results:

  • HFD feeding resulted in impaired glucose tolerance and elevated insulin levels, despite no significant body weight changes.
  • Baseline PMA levels were significantly elevated in HFD-fed mice, indicating hypercoagulation.
  • Baseline monocyte levels (CD14 marker) were significantly decreased in HFD-fed mice.

Conclusions:

  • Short-term HFD feeding induces glucose intolerance, characteristic of a prediabetic state.
  • HFD feeding promotes hypercoagulation, evidenced by increased PMAs.
  • This hypercoagulable state is a significant factor in the development of cardiovascular complications.